Search research articles
Contact Us
Filters
Showing results (331-340 of 512) with videos related to
Page
of 52
Sort By:
Nature Communications
|
December 4, 2018
Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours
Aurélie Durgeau, Yasemin Virk, Gwendoline Gros, et al.
Cancers
|
February 25, 2023
Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma
Pauline Parent, Edouard Auclin, Anna Patrikidou, et al.
Plos One
|
April 3, 2026
PRognostic and predictive potential Of multiparametric dynamic whole-body 18F-FDG PET Imaging using a Long axial field-of-view (LAFOV) system for FIRST-line chemo-immunotherapy efficacy in advanced non-small cell lung cancer: PROFIL-1 study protocol
Margaux Geier, Karim Amrane, David Bourhis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2020
Impact of expert pathologic review of thymic epithelial tumours on diagnosis and management in a real-life setting: A RYTHMIC study
Thierry J Molina, Maria V Bluthgen, Lara Chalabreysse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2022
Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring <i>HER2</i> Mutations: Results From the IFCT-1703 R2D2 Trial
Julien Mazieres, Claire Lafitte, Charles Ricordel, et al.
International Journal of Cancer
|
August 15, 2024
Clinical and molecular features of early onset pancreatic adenocarcinoma
Maxime Rémond, Cristina Smolenschi, Anthony Tarabay, et al.
BMC Cancer
|
July 17, 2016
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer
Mathieu Rouanne, Julien Adam, Aïcha Goubar, et al.
JCO Precision Oncology
|
May 24, 2023
Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma
Stéphane Champiat, Hélène Salaün, Francesca Lucibello, et al.
NPJ Precision Oncology
|
February 16, 2024
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers
Marco Tagliamento, Marie Morfouace, Charalambos Loizides, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 29, 2021
Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis
David Planchard, Benjamin Besse, Harry J M Groen, et al.
Page
of 52
Search research articles
Search
Showing results (331-340 of 512) with videos related to
Sort By:
Page
of 52
Nature Communications
|
December 4, 2018
Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours
Aurélie Durgeau, Yasemin Virk, Gwendoline Gros, et al.
Cancers
|
February 25, 2023
Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma
Pauline Parent, Edouard Auclin, Anna Patrikidou, et al.
Plos One
|
April 3, 2026
PRognostic and predictive potential Of multiparametric dynamic whole-body 18F-FDG PET Imaging using a Long axial field-of-view (LAFOV) system for FIRST-line chemo-immunotherapy efficacy in advanced non-small cell lung cancer: PROFIL-1 study protocol
Margaux Geier, Karim Amrane, David Bourhis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 14, 2020
Impact of expert pathologic review of thymic epithelial tumours on diagnosis and management in a real-life setting: A RYTHMIC study
Thierry J Molina, Maria V Bluthgen, Lara Chalabreysse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2022
Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring <i>HER2</i> Mutations: Results From the IFCT-1703 R2D2 Trial
Julien Mazieres, Claire Lafitte, Charles Ricordel, et al.
International Journal of Cancer
|
August 15, 2024
Clinical and molecular features of early onset pancreatic adenocarcinoma
Maxime Rémond, Cristina Smolenschi, Anthony Tarabay, et al.
BMC Cancer
|
July 17, 2016
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer
Mathieu Rouanne, Julien Adam, Aïcha Goubar, et al.
JCO Precision Oncology
|
May 24, 2023
Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma
Stéphane Champiat, Hélène Salaün, Francesca Lucibello, et al.
NPJ Precision Oncology
|
February 16, 2024
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers
Marco Tagliamento, Marie Morfouace, Charalambos Loizides, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 29, 2021
Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic Analysis
David Planchard, Benjamin Besse, Harry J M Groen, et al.
Page
of 52